Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023:2631:103-134.
doi: 10.1007/978-1-0716-2990-1_4.

Genotyping Genome-Edited Founders and Subsequent Generation

Matthew Mackenzie  1 , Alex Fower  1 , Alasdair J Allan  1 , Gemma F Codner  1 , Rosie K Bunton-Stasyshyn  2 , Lydia Teboul  3
Affiliations

Genotyping Genome-Edited Founders and Subsequent Generation

Matthew Mackenzie et al. Methods Mol Biol. 2023.

Abstract

Targeted nucleases allow the production of many types of genetic mutations directly in the early embryo. However, the outcome of their activity is a repair event of unpredictable nature, and the founder animals that are produced are generally of a mosaic nature. Here, we present the molecular assays and genotyping strategies that will support the screening of the first generation for potential founders and the validation of positive animals in the subsequent generation, according to the type of mutation generated.

Keywords: Allele QC; CRISPR-Cas9; Embryo/zygote engineering; Genetic engineering; Genome editing; Genotyping; Mouse models; Transgenesis.

PubMed Disclaimer

References

    1. Burgio G, Teboul L (2020) Anticipating and identifying collateral damage in genome editing. Trends Genet 36:905–914 - DOI - PubMed - PMC
    1. Mizuno S, Dinh TTH, Kato K et al (2014) Simple generation of albino C57BL/6J mice with G291T mutation in the tyrosinase gene by the CRISPR/Cas9 system. Mamm Genome 25:327–334 - DOI - PubMed
    1. Renaud J-B, Boix C, Charpentier M et al (2016) Improved genome editing efficiency and flexibility using modified oligonucleotides with TALEN and CRISPR-Cas9 Nucleases. Cell Rep 14:2263–2272 - DOI - PubMed
    1. Mianné J, Codner GF, Caulder A et al (2017) Analysing the outcome of CRISPR-aided genome editing in embryos: screening, genotyping and quality control. Methods 121–122:68–76 - DOI - PubMed
    1. Pickar-Oliver A, Gersbach CA (2019) The next generation of CRISPR-Cas technologies and applications. Nat Rev Mol Cell Biol 20:490–507 - DOI - PubMed - PMC

LinkOut - more resources